Description
About BPC-157
BPC-157 is a 15-amino-acid research peptide used in controlled in-vitro investigations of tissue biology and cell-signalling pathways. Originally identified during studies of human gastric juice, the pentadecapeptide carries the sequence GEPPPGKPADDAGLV and a physicochemical profile well suited to exploring cell migration, cell survival, and angiogenic pathways in non-clinical model systems.
Key features of BPC-157
- Synthetic pentadecapeptide (15-amino-acid)
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids)
- Lyophilised solid — stable, easy to store, straightforward to reconstitute
- Unit size: 5 mg / vial
- Every batch released only after identity, purity, and appearance QC
- Certificate of Analysis (CoA) and batch documentation available on request
BPC-157 technical specifications
| Product name | BPC-157 |
| Synonyms | Body Protective Compound-157; Bepecin; PL-14736 |
| Amino-acid sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Class | Synthetic pentadecapeptide (15-amino-acid) |
| Molecular formula | C₆₂H₉₈N₁₆O₂₂ (free base) |
| Molecular weight | ~1,419.5 g/mol |
| CAS number | 137525-51-0 |
| Purity | ≥99% (HPLC) |
| Physical form | Lyophilised powder |
| Appearance | White to off-white solid |
| Unit size | 5 mg / vial |
Reconstituting and storing BPC-157
- Before reconstitution: Store lyophilised vials at 2–8 °C, protected from light and moisture.
- Equilibrate: Allow vial and diluent to reach room temperature before opening.
- Reconstitute: Add Bacteriostatic Water (10 ml recommended). Swirl gently — do not vortex.
- After reconstitution: Store at 2–8 °C. Prepare aliquots to minimise freeze–thaw cycles.
- Compatibility: Use only within protocols that comply with your institution’s SOPs and local regulations.
Looking for complementary materials? See Bacteriostatic Water 10ml, TB-500 5mg, GHK-Cu 50mg.
BPC-157 in research
BPC-157 is used in laboratory research to investigate cell migration, cell survival, extracellular-matrix dynamics, and angiogenic signalling in non-clinical model systems. Its defined pentadecapeptide structure and lyophilised stability profile support reproducible readouts across diverse in-vitro assays.
Synthesis and quality assurance
Avanti Peptides manufactures BPC-157 via controlled, validated solid-phase peptide synthesis (SPPS) to deliver high purity and lot-to-lot consistency. Each batch undergoes identity verification, HPLC purity analysis (≥99%), and appearance inspection before release.




